It has been reported that AA genotype, which is associated with lower intrahepatic expression of MERTK, is protective against severe fibrosis also in Non-Alcoholic Fatty Liver Disease (NAFLD) through a mechanism involving the modulation of HCS activation (11). This evidence concerns the gene MERTK and metabolic dysfunction-associated steatotic liver disease.